CClinicalTrials.gg
CompletedNCT03637036Updated Jan 23, 2019

An Improvement Project Around Staffs' Influenza Vaccine Uptake

An interventional study of Communication intervention in Influenza Vaccination, sponsored by University of Warwick. Completed at 1 site in United Kingdom. Per ClinicalTrials.gov, last updated 2019-01-23.

Sponsored by University of Warwick · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
8,438
Allocation
Randomized
Sex
All
01

Study summary

To reach seasonal vaccination against influenza targets, University Hospitals Birmingham (UHB) already invites staff to take up the vaccination, and every November reminds staff that have not yet vaccinated to do so. The current protocol describes a randomized controlled trial (RCT) in which staff will be sent different reminders, and the investigators will compare the proportion of staff that go on to vaccinate after receiving each reminder.

Read the detailed description

Seasonal vaccination against influenza is recommended for NHS staff. , To increase vaccination rates, NHS England put forth a Commissioning for Quality and Innovation goal for the 2018/2019 season of 75%. University Hospitals Birmingham NHS Foundation Trust (UHB) wants its vaccination rate to surpass this target. Since staff get infected outside of the hospital and from patients staff vaccination does not provide significant 'herd immunity'

To reach past targets, every September UHB already invites staff to take up the vaccination, and regularly reminds staff that have not yet vaccinated to do so. The current protocol describes a randomized controlled trial (RCT) in which staff will be sent a different letter when first invited to receive vaccination, and we will compare the proportion of staff that go on to vaccinate after receiving each type of letter..

To conduct the RCT the research team will design four letter styles. One factor will emphasize an authority figure inviting staff to vaccinate (the Chief Executive, who is also a doctor). The other factor will emphasize a competitive social norm describing vaccination rates in peer hospitals, including Addenbrooke's, Cambridge University Hospitals (which has exemplary rates) see appendix A and across American hospitals (which also have high rates). Letters will be sent to staff in the first week in October by UHB's communications team and they will be disseminated in a randomized fashion.

The UoW's role in this study is to advise the study's design and write-up the project for publication. UHB will approve the reminders, send the reminders, retrieve the data, and analyse the data. No individual-level data will be transferred across organizations. All individual-level data will be managed by authorized UHB employees, e.g., a UHB statistician will randomize staff to receive different reminders and analyze the data, and UHB's communication team to disseminate the reminders.

02

Conditions studied

  • Influenza Vaccination

Browse trials for

03

In context

Influenza, Human

2,214 studies on the registry are indexed under Influenza, Human; 163 are open to participants now.

This study's enrollment of 8,438 is above the median of 238 across 1,853 interventional studies indexed under Influenza, Human.

Browse Influenza, Human studies →

Lead sponsor

University of Warwick is the lead sponsor of 26 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  • All UHB staff eligible for the seasonal influenza vaccination are eligible for this study. (no patients are included)
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
8,438 participants (actual)

Study arms

  • Other
    Control Condition

    A general communication intervention will occur inviting staff to take up the influenza vaccination, without a specific authority or social norm designated.

    Other: Communication intervention

  • Other
    Authority Condition

    A communication intervention will occur inviting staff to take up the influenza vaccination with a specific authority but not a social norm designated.

    Other: Communication intervention

  • Other
    Norms Condition

    A communication intervention will occur inviting staff to take up the influenza vaccination with a social norm but not a specific authority designated.

    Other: Communication intervention

  • Other
    Authority + Norms Condition

    A communication intervention will occur inviting staff to take up the influenza vaccination with a specific authority and a social norm designated.

    Other: Communication intervention

Interventions

  • OtherCommunication intervention

    The intervention is a communication inviting staff to take up the influenza vaccination. Different versions of the communication are created, and the investigators will compare uptake rates between staff that received different letters.

06

What researchers measure

Primary outcomes

  1. Vaccination uptake

    Whether participants vaccinated (Yes, No)

    Time frame: 3 months

Secondary outcomes

  1. Vaccination uptake date

    The date participants received vaccination (DD-MM-YYYY or blank if not vaccinated)

    Time frame: 3 months

  2. Vaccination uptake reflusal

    Whether participants formally indicated refusal to vaccinate (Yes, No)

    Time frame: 3 months

  3. Vaccination uptake alternative location

    Whether participants formally indicated being vaccinated at another location (Yes, No)

    Time frame: 3

Other outcomes

  1. Group number

    This data describes what communication participants received

    Time frame: 3 months

  2. Worksite

    This data describes what location within the organization participants work

    Time frame: 3 months

  3. Job Role

    This data describes participants' job roles

    Time frame: 3 months

  4. Gender

    This data describes participants' gender

    Time frame: 3 months

07

Study locations

1 site
  • University Hospitals Birmingham NHS Foundation Trust (UHB)
    Birmingham, B15 2GW, United Kingdom
08

References and documents

Study documents

  • Protocol and statistical analysis plan · Sep 7, 2018

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — Individual data will not be shared.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 23, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03637036
Lead sponsor
University of Warwick
Collaborators
University Hospital Birmingham
Responsible party
Professor Richard Lilford (Professor of Public Health, University of Warwick) — Principal investigator
First posted
Aug 17, 2018
Start date
Sep 24, 2018
Primary completion
Jan 4, 2019
Completion
Jan 4, 2019
Last update
Jan 23, 2019

Study contacts

Richard J Lilford
principal investigator · University of Warwick

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion